Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma
10.1097/IJG.0b013e318050ab7a
Saved in:
Main Authors: | Kumar, R.S., Istiantoro, V.W., Hoh, S.-T., Ho, C.-L., Oen, F.T., Aung, T. |
---|---|
Other Authors: | OPHTHALMOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension
by: Topouzis, F., et al.
Published: (2016) -
Intraocular pressure-lovering effect and safety of travoprost 0.004% and latanoprost 0.005% for the treatment of chronic angle closure glaucoma
by: Chew, P.T.K., et al.
Published: (2016) -
Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma
by: Chew, P.T.K., et al.
Published: (2014) -
Current status of prostaglandin therapy: Latanoprost and unoprostone
by: Susanna Jr., R., et al.
Published: (2014) -
Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride
by: Wong, T.T, et al.
Published: (2020)